Motor Stereotypic Behavior Was Associated With Immune Response in Macaques: Insight From Transcriptome and Gut Microbiota Analysis

Linking Gut Microbiota and Stereotypic Behavior of Endangered Species Under Ex Situ Conservation: First Evidence from Sun Bears

Integrative conservation research on animal behavior and nutritional health can contribute to the ex situ conservation of endangered species. Stereotypic behavior, a repetitive behavior without practical function, is associated with animal welfare in its manner and frequency for captive animals. Exploring the potential relationship between stereotypic behavior and internal factors, such as intestinal flora, could improve ex situ conservation, especially for endangered species. In this study, we analyzed the typical behavior characteristics of the endangered sun bears (Helarctos malayanus) under captive conditions based on the behavior sampling method. The seasonal and annual changes in the intestinal flora of H. malayanus in captivity were studied by 16S rDNA high-throughput sequencing technology based on non-invasive fecal sample collection. This study provides the first evidence of a potential association between the gut microbiota and stereotypic behavior characteristics of captive H. malayanus. The results can significantly improve our understanding of the stereotypical behavior of H. malayanus in captivity and contribute to the captive breeding and conservation efforts of this endangered species.

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure

Aims: Pathological left ventricular (LV) remodeling induced by multiple causes often triggers fatal cardiac dysfunction, heart failure (HF), and even cardiac death. This study is aimed to investigate whether qiliqiangxin (QL) could improve LV remodeling and protect against HF via modulating gut microbiota and inhibiting nod-like receptor pyrin domain 3 (NLRP3) inflammasome activation.

Methods: Rats were respectively treated with QL (100 mg/kg/day) or valsartan (1.6 mg/kg/day) by oral gavage after transverse aortic constriction or sham surgery for 13 weeks. Cardiac functions and myocardial fibrosis were assessed. In addition, gut microbial composition was assessed by 16S rDNA sequencing. Furthermore, rats’ hearts were harvested for histopathological and molecular analyses including immunohistochemistry, immunofluorescence, terminal-deoxynucleotidyl transferase-mediated 2’-deoxyuridine 5’-triphosphated nick end labeling, and Western blot.

Key findings: QL treatment preserved cardiac functions including LV ejection fractions and fractional shortening and markedly improved the LV remodeling. Moreover, HF was related to the gut microbial community reorganization like a reduction in Lactobacillus, while QL reversed it. Additionally, the protein expression levels like IL-1β, TNF-α, NF-κB, and NLRP3 were decreased in the QL treatment group compared to the model one.

Conclusion: QL ameliorates ventricular remodeling to some extent in rats with HF by modulating the gut microbiota and NLRP3 inflammasome, which indicates the potential therapeutic effects of QL on those who suffer from HF.